Cell Therapeutics, Inc. Pulls EU Application for Lung Drug Opaxio
Reuters -- Cell Therapeutics has withdrawn its European marketing application for its lung drug Opaxio, after an EU panel raised concerns over the trial design, Europe's drug regulator said on Wednesday.